Doç. Dr. BANU AYDIN OMAY

Makaleler 32

1. Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines.

Naunyn-Schmiedeberg's archives of pharmacology , cilt.397, sa.10, ss.7913-7926, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

2. Ethosuximide-loaded bismuth ferrite nanoparticles as a potential drug delivery system for the treatment of epilepsy disease

Guldorum Y., Ayran M., Bulut B., Ilgar S., Ulag S., Kanli Z., et al.

PLoS ONE , cilt.19, sa.9, 2024 (SCI-Expanded, Scopus)

3. The role of epidermal growth factor and cholinergic receptor agonists and antagonists in MAPK signal transduction in K562 cells

Atmaca S. G., Aydın Omay B., Cabadak H.

MARMARA MEDICAL JOURNAL , cilt.1, sa.37, ss.86-91, 2024 (ESCI)

4. Potential antiproliferative and apoptotic effects of pilocarpine combined with TNF alpha in chronic myeloid leukemia cells

Kanlı Z., Cabadak H., Aydın Omay B.

Naunyn-Schmiedeberg's Archives of Pharmacology , cilt.396, sa.7, ss.1513-1524, 2023 (SCI-Expanded, Scopus)

5. Fabrication of ethosuximide loaded alginate/polyethylene oxide scaffolds for epilepsy research using 3D-printing method

Karabulut H., Dutta A., Moukbil Y., Cisen Akyol A., ULAĞ S., Aydin B., et al.

Frontiers in Bioengineering and Biotechnology , cilt.11, 2023 (SCI-Expanded, Scopus)

6. Effects of Melatonin Supplementation and Different Exercise Models on Cognitive Function in Long-Term Exposure to Constant Light in Rats

Erol G., Dincer B. E., Calik H. N., Oksuz H., YILDIRIM H. S., Sener D., et al.

ACTA PHYSIOLOGICA , cilt.237, ss.16, 2023 (SCI-Expanded)

7. The effect of acute topiramate administration on morphine withdrawal syndrome and brain-derived neurotrophic factor in central nervous system

Ozkula S., Jafarova Demirkapu M., Yananli H. R., Aydin B., Nacar C., Cabadak H.

NEUROLOGICAL RESEARCH , cilt.45, sa.8, ss.730-737, 2023 (SCI-Expanded)

8. The Effect of Metformin on Ethanol- and IndomethacinInduced Gastric Ulcers in Rats

İpek B. E., Yüksel M., Cumbul A., Ercan F., Cabadak H., Aydın Omay B., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.9, ss.767-776, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Cross-talk of cholinergic and beta-adrenergic receptor signalling in chronic myeloid leukemia K562 cells

Aydın Omay B., Gören M. Z., Kanli Z., Cabadak H.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , cilt.49, sa.4, ss.515-524, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

10. Decreased Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 2 Activity in a Rat Model of Absence Epilepsy and the Effect of ZD7288, an Ih Inhibitor, on the Spike-and-Wave Discharges

Yavuz M., Aydın Omay B., Carcak N., Onat F.

PHARMACOLOGY , cilt.107, ss.227-234, 2022 (SCI-Expanded, Scopus)

11. Studies on the role of alpha 7 nicotinic acetylcholine receptors in K562 cell proliferation and signaling

Önder Narin G., Aydın B., Cabadak H.

MOLECULAR BIOLOGY REPORTS , cilt.48, sa.6, ss.5045-5055, 2021 (SCI-Expanded, Scopus)

12. Atipamezole, a specific alpha(2A) antagonist, suppresses spike-and-wave discharges and alters Ca2+/calmodulin-dependent protein kinase II in the thalamus of genetic absence epilepsy rats

Yavuz M., Aydın Omay B., Carcak N., Akman O., Raci Yananli H. R., Onat F.

EPILEPSIA , cilt.61, ss.2825-2835, 2020 (SCI-Expanded)

13. The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model

Ketenci S., Acet N. G., Sarıdoğan G. E., Aydın B., Cabadak H., Gören M. Z.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE , cilt.18, ss.219-230, 2020 (SCI-Expanded, Scopus)

14. Role of cholinergic agents in proliferation and caspase activity of hemin-induced erythroid differentiated K562 cells

Cabadak H., Aydın B.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , cilt.40, ss.42-48, 2020 (SCI-Expanded)

15. Investigation of the Role of M3 muscarinic receptor in Chronic Myeloid Leukemic Cells.

Kanlı Z., Aydın B., Cabadak H.

TURKISH JOURNAL OF BIOLOGY , cilt.43, sa.5, ss.70, 2019 (SCI-Expanded)

16. The Effect of Cholinergic Receptors Agonist/ Antagonists Together with Anticancer Drug 5-FU in Hepatocellular Carcinoma

Tanrıverdi A. M., Küçük O. Y., Aydın B., Cabadak H.

TURKISH JOURNAL OF BIOLOGY , cilt.43, sa.5, ss.24, 2019 (SCI-Expanded)

17. Contribution of M-1 and M-2 muscarinic receptor subtypes to convulsions in fasted mice treated with scopolamine and given food

Bacanak M., Aydın B., Cabadak H., Nurten A., Goren M. Z., Enginar N.

BEHAVIOURAL BRAIN RESEARCH , cilt.364, ss.423-430, 2019 (SCI-Expanded)

18. Effects of cholinergic compounds and TNF-alpha on human erythroleukemia K562 cell proliferation and caspase expression

Kanli Z., Aydın B., Cabadak H.

MARMARA MEDICAL JOURNAL , cilt.32, ss.20-26, 2019 (ESCI)

19. The behavioral and neurochemical effects of methylprednisolone and metyrapone in a post-traumatic stress disorder rat model

Tanriverdi Bademci A. M., Aydın B., Terzioğlu Bebitoğlu B., Cabadak H., Gören M. Z.

Northern Clinics of Istanbul , cilt.6, sa.4, ss.327-333, 2019 (Hakemli Dergi)

20. Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line

Aydın B., Tulunay A., Eksioglu-Demiralp E., Kan B., Cabadak H.

MARMARA MEDICAL JOURNAL , cilt.32, ss.38-43, 2019 (ESCI)

21. Kronik Miyeloid Lösemi Hücrelerinde Kolinerjik Sistemin TNF alfa ile Uyarılan IL-8 SalınımınaEtkisi

Cabadak H., Kanlı Z., Aydın B.

Acibadem University Health Sciences Journal , cilt.9, 2018 (Hakemli Dergi)

22. Investigation of the Roles of Non-neuronal Acetylcholine in Chronic Myeloid Leukemic Cells and their Erythroid or Megakaryocytic Differentiated Lines

Aydın B., Cabadak H., Gören M. Z.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.18, ss.1440-1447, 2018 (SCI-Expanded, Scopus)

23. Beta Adrenerjik Agonist ve Antagonistlerin K562 Kronik Miyeloid Lösemi Hücrelerinde Kaspaz 3,Kaspaz 8 ve Kaspaz 9 Ekspresyonuna Etkisi.

Aydın B., Gören M. Z., Cabadak H.

Acıbadem Üniversitesi Sağlık Bilimleri dergisi , cilt.9, 2018 (Hakemli Dergi)

24. The Effect of Low Dose Sildenafil on Verapamil–Induced Cardiovascular Toxicity in Rats

Gül F., Duman N., Arslantas M. K., Aydın B., Cabadak H., Haliloğlu M., et al.

SOJ Anesthesiology Pain Management , cilt.4, ss.1-4, 2017 (Hakemli Dergi)

25. The role of GluN1 activated nitric oxide synthase in a rat model of post-traumatic stress disorder

Ayhan B. G., Aykac A., Gur K., Aydın B., Secgin E., Seven I., et al.

MARMARA MEDICAL JOURNAL , cilt.29, ss.67-72, 2016 (ESCI)

26. The role of intracellular pathways in the proliferation of human K562 cells mediated by muscarinic receptors

Aydın B., Kan B., Cabadak H.

LEUKEMIA RESEARCH , cilt.37, ss.1144-1149, 2013 (SCI-Expanded)

27. Increased Noradrenaline Levels in the Rostral Pons can be Reversed by M1 Antagonist in a Rat Model of Post-traumatic Stress Disorder

Terzioglu B., Kaleli M., Aydin B., Ketenci S., Cabadak H., Gören M. Z.

NEUROCHEMICAL RESEARCH , cilt.38, sa.8, ss.1726-1733, 2013 (SCI-Expanded, Scopus)

28. Muscarinic Agonist, Antagonists and Signaling Pathway Inhibitors Change c-Fos And Cyclin D1 Expression in K562 Cells

Cabadak H., Aydın B., Kan B.

MARMARA MEDICAL JOURNAL , cilt.26, ss.72-76, 2013 (Scopus)

29. The change in muscarinic receptor subtypes in different brain regions of rats treated with fluoxetine or propranolol in a model of post-traumatic stress disorder

Aykac A., Aydın B., Cabadak H., Gören M. Z.

BEHAVIOURAL BRAIN RESEARCH , cilt.232, ss.124-129, 2012 (SCI-Expanded)

30. Regulation of M-2, M-3, and M-4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol

Cabadak H., Aydın B., Kan B.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION , cilt.31, ss.26-32, 2011 (SCI-Expanded, Scopus)

31. Muscarinic receptor mediated cAMP response in human K562 chronic myelogenous leukemia cells

Cabadak H., Aydın B., Kan B.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.36, ss.188-192, 2011 (SCI-Expanded)

32. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line

Cabadak H., Kücükibrahimoğlu E., Aydın B., Kan B., Gören M. Z.

Autonomic and Autacoid Pharmacology , cilt.29, ss.109-115, 2009 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 63

1. DİRENÇLİ EPİLEPSİ TEDAVİSİNE YÖNELİK ENJEKTE EDİLEBİLİR FENİTOİN-PLGA NANOPARTİKÜL YÜKLÜ SİLKMA HİDROJELİNİN ÜRETİMİ VE KARAKTERİZASYONU

Baykara D., ULAĞ S., ALARÇİN E., GÜNDÜZ O., AYDIN OMAY B.

4. ULUSAL BİLİMSEL ARAŞTIRMALAR KONGRESİ, Türkiye, 16 Temmuz 2024, (Özet Bildiri)

2. Gelatin Methacryloyl (GELMA) Microneedles for Localized Delivery of Antiepileptic Drugs Loaded on Bismuth Ferrite (BFO) and Polylactic-co-Glycolic Acid (PLGA) Particles

ERŞAN Y., Ilgar S., Akdag Z., Pilavci E., ULAĞ S., ALARÇİN E., et al.

“Applications of Chemistry in Nanosciences and Biomaterials Engineering, Romanya, 19 - 21 Haziran 2024, (Özet Bildiri)

3. Fabrication of ethosuximide loaded polycaprolactone/bismuth ferrite-based 3D-printed scaffolds and controlled drug release in electric field for the treatment of epilepsy

Akyol A., ÖZDEMİR E., KARABULUT H., ULAĞ S., KANLI Z., AYDIN OMAY B., et al.

Applications of Chemistry in Nanosciences and Biomaterials Engineering, Romanya, 19 Haziran - 21 Temmuz 2024, (Özet Bildiri)

4. EPILEPSI TEDAVISINDE KONTROLLÜ VALPROAT SALIMI IÇIN HIDROJEL TABANLI MIKROIĞNELERIN GELIŞTIRILMESI

US Z., Kanlı Z., AYDIN OMAY B., GÜLHAN R., İlgar S., Guldorum Y., et al.

2. ULUSLARARASI 27. ULUSAL FARMAKOLOJİ KONGRESİ 2 nd INTERNATIONAL AND 27th NATIONAL PHARMACOLOGY CONGRESS, Türkiye, 23 Kasım 2023, (Özet Bildiri)

5. Effect of Chemotherapy Drugs Combined with Flavonoid on Colorectal Cancer Cells

KANLI Z., AYDIN OMAY B., ERZİK C., ARĞA K. Y., CABADAK H.

International Marmara Sciences Congress, Kocaeli, Türkiye, 9 - 10 Aralık 2022, ss.41, (Özet Bildiri)

6. HEPATOSELLÜLER KARSİNOMADA GLUT1 İNHİBİTÖRÜ BAY-876’NIN HEPG2 HÜCRELERİNDE VE STEATOZ HÜCRE MODELİNDE GLUKOZ ALIMI VE HÜCRE ÇOĞALMASINA ETKİSİ

Tanriverdi Bademci A. M., Aydın Omay B., Cabadak H.

9. ULUSLARARASI MARMARA FEN BİLİMLERİ KONGRESİ, Kocaeli, Türkiye, 09 Aralık 2022, (Özet Bildiri)

7. Effects of Melatonin Supplementation and Different Exercise Models on Cognitive Function in Long-Term Exposure to Constant Light in Rats

Erol G., Dinçer B. E., Çalık H. N., Öksüz H., Yıldırım S., ŞENER AKÇORA D., et al.

47. Ulusal Fizyoloji Kongresi, Antalya, Türkiye, 01 Kasım 2022, (Özet Bildiri)

8. METİLPREDNİZOLON VE METİRAPON TEDAVİLERİNİN TRAVMA SONRASI STRES BOZUKLUĞUNDA NÖROKİMYASAL ETKİLER

TANRİVERDİ BADEMCİ A. M., AYDIN OMAY B., GÖREN M. Z., CABADAK H.

6th INTERNATIONAL MARMARA SCIENCES CONGRESS IMASCON 2021 SPRING, Yalova, Türkiye, 21 - 22 Mayıs 2021, 21 Mayıs 2021, sa.0, (Özet Bildiri)

9. Metilprednizolon ve metirapon tedavilerinin travma sonrası stres bozukluğunda nöro- kimyasal etkileri

TANRİVERDİ BADEMCİ A. M., AYDIN OMAY B., GÖREN M. Z., CABADAK H.

International Marmara Sciences Congress (Spring) 2021, Kocaeli, Türkiye, 21 - 22 Mayıs 2021, (Özet Bildiri)

10. M2 and M3 Muscarinic Receptor Expression in Bladder Cancer Cells

Asutay K., Aydın Omay B., Toper M. H., Filinte D., Cabadak H., Tinay İ.

The International Congress of Future Medical Pioneers 2021, Türkiye, 08 Mayıs 2021, (Tam Metin Bildiri)

11. Roles Of Cholinergic Nicotinic Receptors In Human Myelogenous Leukemia K562 Cell Lin

Narin G., Aydın Omay B., Cabadak H.

8th Multidisciplinary Cancer Research Congress, İstanbul, Türkiye, 16 - 18 Ocak 2021, ss.154, (Özet Bildiri)

12. Roles of cholinergic nicotinic receptors in human myelogenous leukemia K562 cell line

AYDIN OMAY B., CABADAK H.

8th Multidisciplinary Cancer Research Congress, İstanbul, Türkiye, 16 Ocak 2021, (Özet Bildiri)

13. Effects of Cholinergic and EGF Receptors Antagonists on HEPG2 and Steatotic HEPG2 Cell Proliferation

AYDIN B.

IMASCON 2020 SPRING, 19 - 20 Haziran 2020, (Özet Bildiri)

14. Muskarinik Reseptörüne Özgü Agonist ve Antagonistlerin , İnsan Kronik Miyeloid Lösemi Hücrelerinde Sitokrom C, Kaspaz 3, 8ve 9 Ekspresyonuna Etkileri

Kanlı Z., Aydın B., Cabadak H.

31.Ulusal Biyofizik Kongresi, Adana, Türkiye, 9 - 12 Ekim 2019, ss.30-31, (Özet Bildiri) Sürdürülebilir Kalkınma

15. Studies on Effects of Cholinergic Agonist/Antagonist and 5-FU on HEPG2 and Steatotic HEPG2 Cell Proliferation and Apoptosis

Küçük O., Tanrıverdi A. M., Aydın B., Cabadak H.

Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, cilt.1, ss.29, (Özet Bildiri)

16. The Effect of Cholinergic Receptors Agonist/ Antagonists Together with Anticancer Drug 5-FU in Hepatocellular Carcinoma

Tanrıverdi A. M., Küçük O., Aydın B., Cabadak H.

MolBioKon 2019, İstanbul, Türkiye, 27 - 29 Eylül 2019, (Özet Bildiri)

17. Investigation of the Role of M3 Muscarinic Receptor in Chronic Myeloid Leukemic Cells

Kanlı Z., Aydın B., Cabadak H.

MolBioKon 2019, İstanbul, Türkiye, 27 - 29 Eylül 2019, (Özet Bildiri) Sürdürülebilir Kalkınma

18. The effect of epidermal growth factor and cholinergic receptors agonist /antagonists together with anticancer drug 5-FU in hepatocelluler carcinomacell line

Kucuk O., Tanrıverdi A. M., Aydın B., Cabadak H.

Horizons in Molecular Biology Symposium 2019, Göttingen, Almanya, 9 - 12 Eylül 2019, cilt.1, ss.80, (Özet Bildiri) Sürdürülebilir Kalkınma

19. The effect of combination of cholinergic agonist and antagonist onapoptosis in megacaryocytic differentiated K562 leukemia cells.

Cabadak H., Aydın B.

16th Horizons in Molecular Biology Göttingen-Germany, Göttingen, Almanya, 9 - 12 Eylül 2019, cilt.1, ss.127, (Özet Bildiri)

20. Alfa 7 nikotinik asetil kolin reseptörlerinin K562 hücre çoğalması ve sinyal iletisindeki rolleri üzerine çalışmalar

Önder G., AYDIN B., CABADAK H.

2.Marmara Eczacılık kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)

21. The Effect of Beta Adrenergic Agonist and Antagonists on Caspase 3, Caspase 8 and Caspase 9 Expression on K562 Chronic Myeloid Leukemia Cells.

Aydın B., Kanlı Z., Gören M. Z., Cabadak H.

Europhysiology18, London, Birleşik Krallık, 14 - 16 Eylül 2018, ss.152, (Özet Bildiri)

22. Cholinergic receptor agonist, carbachol, induces M1 and M4 muscarinic receptors expression in megakaryocytic differentiated K562 cells

CABADAK H., AYDIN B.

Europhysiology, Londrina, Birleşik Krallık, 14 - 16 Eylül 2018, (Özet Bildiri)

23. Regulation of acethylcholineesterase activity, CXCL8 production and proliferation by pilocarpine in hHuman K562 eErythroleukemia cells

Kanlı Z., AYDIN B., CABADAK H.

Europhysiology18, Londrina, Birleşik Krallık, 14 - 16 Eylül 2018, ss.152, (Özet Bildiri)

24. M2 AND M3 MUSCARINIC RECEPTOR EXPRESSION IN BLADDER TUMOR

Asutay K., AYDIN B., TOPER M. H., FİLİNTE D., CABADAK H., TİNAY İ.

AMERICAN UROLOGICAL ASSOCIATION (AUA 2018), Amerika Birleşik Devletleri, 18 - 21 Mayıs 2018, cilt.199, ss.778, (Özet Bildiri)

25. Scopolamine-induced convulsions in fasted mice after food intake: determination of M1 and M2 muscarinic receptor expressions in brain regions

Bacanak Saygı M., AYDIN B., CABADAK H., GÖREN M. Z., NURTEN A., ENGİNAR N., et al.

ECNP 30th, 2 - 05 Ağustos 2017, cilt.27, ss.661, (Özet Bildiri)

26. The effect of valproic acid in the dorsal hippocampus in a rat model of post-traumatic stress disorder

Acet N. G., Ketenci S., Aydin B., Cabadak H., Goren Z.

30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, Fransa, 2 - 05 Eylül 2017, cilt.27, (Özet Bildiri)

27. Scopolamine-induced convulsions in fasted mice after food intake: determination of M1 and M2 muscarinic receptor expressions in brain regions

Bacanak M. S., Aydin B., Cabadak H., Goren M. Z., Nurten A., Enginar N.

30th Congress of the European-College-of-Neuropsychopharmacology (ECNP), Paris, Fransa, 2 - 05 Eylül 2017, cilt.27, (Özet Bildiri)

28. Scopolamine-induced convulsions in fasted mice after food intake: determination of M1 and M2 muscarinic receptor expressions in brain regions

BACANAK M., AYDIN B., CABADAK H., NURTEN A., GÖREN M. Z., ENGİNAR N.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, Paris, Fransa, 2 - 05 Eylül 2017, cilt.27, ss.661, (Özet Bildiri)

29. Beta Adrenerjik Agonist ve Antagonistlerin K562 Kronik Miyeloid Lösemi Hücrelerinde Kaspaz 3, Kaspaz 8 ve Kaspaz 9 Ekspresyonuna Etkisi

AYDIN B., GÖREN M. Z., CABADAK H.

Biyofizik Kongresi, Türkiye, 6 - 09 Ağustos 2017, (Özet Bildiri)

30. Kronik Miyeloid Lösemi Hücrelerinde Kolinerjik Sistemin TNF alfa ile Uyarılan IL-8 Salınımına Etkisi

Cabadak H., Kanlı Z., Aydın B.

Biyofizik kongresi, İstanbul, Türkiye, 6 - 09 Ağustos 2017, cilt.9, ss.65, (Özet Bildiri)

31. The Effect of Valproic Acid in theDorsal Hippocampus in a Rat Model of Post-traumatic Stress Disorder

Acet G., KETENCİ S., AYDIN B., CABADAK H., GÖREN M. Z.

ECNP 30 th, 2 - 05 Ağustos 2017, cilt.27, ss.584, (Özet Bildiri)

32. BEYAZ MTA VE 4-META/MMA-TBB ESASLI ADEZİV REZİNİNSİTOTOKSİSİTELERİNİN KARŞILAŞTIRILMASI

KÖRKLÜ S., SAZAK ÖVEÇOĞLU H., AYDIN B., CABADAK H.

7. Uluslararası Endodonti Sempozyumu, 11 - 14 Mayıs 2017, (Özet Bildiri)

33. İnsan Kronik myeloid eritrolösemi hücrelerinde epidermal growth faktörün ve kolinerjik reseptör agonist ve antagonistlerinin Mapk sinyal iletiminde rolü

Güler S., AYDIN B., CABADAK H.

Kök hücre sempozyumu, Türkiye, 08 Nisan 2016, (Özet Bildiri)

34. İnsan Kronik myeloid eritrolösemi hücrelerinde epidermal growth faktörün ve kolinerjik reseptör agonist ve antagonistlerinin Mapk sinyal iletiminde rolü Poster

Güler S., AYDIN B., CABADAK H.

. Kök hücre sempozyumu, Türkiye, 08 Nisan 2016, (Özet Bildiri)

35. Association Study of TRPM8 rs10166942 Polymorphism in a Turkish Population with Migraine

Begüm Ç. G., Cantürk A., AYDIN B., Candan F., Koçer A., CABADAK H.

1st Pharmacogenomics, 27 - 30 Kasım 2015, (Özet Bildiri)

36. Non neuronal cholinergic system in megacaryocytic differentiated K562 cells

CABADAK H., AYDIN B.

3. International Conference on Hematology Blood DisordersNovember 02-04, 2015 Atlanta, USA, 2 - 04 Kasım 2015, cilt.6, (Özet Bildiri)

37. Effects of propranolol on human erythroid differentiated K562 cell proliferation

Ugurdag A., AYDIN B., GÖREN M. Z., CABADAK H.

4th International Congress of Molecular Biology Association of Turkey (MolBiyoKon 2015, 27 - 29 Kasım 2015, (Özet Bildiri)

38. Effects of Pilocarpine in Human Erythroleukemia K562 cell proliferation

Kanlı Z., AYDIN B., CABADAK H.

4th International Congress of Molecular Biology Association of Turkey, 27 - 29 Kasım 2015, (Özet Bildiri)

39. Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge

Cakıcı B., Aydın Cantürk İ., Aydın B., Candan F., Cabadak H.

1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders., İstanbul, Türkiye, 27 - 28 Kasım 2015, cilt.1, sa.8, ss.81-0, (Özet Bildiri)